157 related articles for article (PubMed ID: 1633226)
21. Effect of vitamin-E-modified dialysers on dialyser clotting, erythropoietin and heparin dosage: a comparative crossover study.
Huraib S; Tanimu D; Shaheen F; Hejaili F; Giles C; Pagayon V
Am J Nephrol; 2000; 20(5):364-8. PubMed ID: 11092992
[TBL] [Abstract][Full Text] [Related]
22. Does the method of heparinisation influence the biocompatibility of dialysis membranes?
Otte KE; Jensen TM; Knudsen F; Antonsen S; Jørgensen KA
Nephrol Dial Transplant; 1991; 6(1):62-5. PubMed ID: 2057121
[TBL] [Abstract][Full Text] [Related]
23. Comparison of blood biocompatibility during haemodialysis with cuprophane and polyacrylonitrile membranes.
Seyfert UT; Helmling E; Hauck W; Skroch D; Albert W
Nephrol Dial Transplant; 1991; 6(6):428-34. PubMed ID: 1876284
[TBL] [Abstract][Full Text] [Related]
24. Granulocyte sequestration in dialysers: a comparative elution study of three different membranes.
Grooteman MP; Nubé MJ; van Houte AJ; Schoorl M; van Limbeek J
Nephrol Dial Transplant; 1995 Oct; 10(10):1859-64. PubMed ID: 8592594
[TBL] [Abstract][Full Text] [Related]
25. Comparison of two dialysers (AN69ST vs. FX100) for heparin-free dialysis in patients with oral anticoagulation.
Kodras K; Benesch T; Neumann I; Haas M
Blood Purif; 2008; 26(3):226-30. PubMed ID: 18305385
[TBL] [Abstract][Full Text] [Related]
26. Acute intradialytic well-being: results of a clinical trial comparing polysulfone with cuprophan. Bergamo Collaborative Dialysis Study Group.
Kidney Int; 1991 Oct; 40(4):714-9. PubMed ID: 1745022
[TBL] [Abstract][Full Text] [Related]
27. Complement activation during hemodialysis: clinical observations, proposed mechanisms, and theoretical implications.
Chenoweth DE
Artif Organs; 1984 Aug; 8(3):281-90. PubMed ID: 6332607
[TBL] [Abstract][Full Text] [Related]
28. Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers.
Smeby LC; Widerøe TE; Balstad T; Jørstad S
Blood Purif; 1986; 4(1-3):93-101. PubMed ID: 3730167
[TBL] [Abstract][Full Text] [Related]
29. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
[TBL] [Abstract][Full Text] [Related]
30. Clinical manifestations of AB-amyloidosis: effects of biocompatibility and flux.
Schiffl H; Fischer R; Lang SM; Mangel E
Nephrol Dial Transplant; 2000 Jun; 15(6):840-5. PubMed ID: 10831638
[TBL] [Abstract][Full Text] [Related]
31. Activation of platelets, coagulation and fibrinolysis in patients on long-term haemodialysis: influence of cuprophan and polyacrylonitrile membranes.
Sultan Y; London GM; Goldfarb B; Toulon P; Marchais SJ
Nephrol Dial Transplant; 1990; 5(5):362-8. PubMed ID: 2142756
[TBL] [Abstract][Full Text] [Related]
32. Ex vivo model of hemodialysis membrane biocompatibility.
Spencer PC; Schmidt B; Samtleben W; Bosch T; Gurland HJ
Trans Am Soc Artif Intern Organs; 1985; 31():495-8. PubMed ID: 3879781
[No Abstract] [Full Text] [Related]
33. Comparison of the effects of cellulose triacetate and polysulfone membrane on GPIIb/IIIa and platelet activation.
Kuragano T; Kuno T; Takahashi Y; Yamamoto C; Nagura Y; Takahashi S; Kanmatsuse K
Blood Purif; 2003; 21(2):176-82. PubMed ID: 12601261
[TBL] [Abstract][Full Text] [Related]
34. Haemodialysis-induced leucopenia and activation of complement: effects of different membranes.
Aljama P; Bird PA; Ward MK; Feest TG; Walker W; Tanboga H; Sussman M; Kerr DN
Proc Eur Dial Transplant Assoc; 1978; 15():144-53. PubMed ID: 740661
[TBL] [Abstract][Full Text] [Related]
35. Biocompatibility of different hemodialysis membranes: activation of complement and leukopenia.
Wegmüller E; Montandon A; Nydegger U; Descoeudres C
Int J Artif Organs; 1986 Mar; 9(2):85-92. PubMed ID: 3699914
[TBL] [Abstract][Full Text] [Related]
36. Acute effect of haemodialysis on arterial stiffness: membrane bioincompatibility?
Mourad A; Carney S; Gillies A; Jones B; Nanra R; Trevillian P
Nephrol Dial Transplant; 2004 Nov; 19(11):2797-802. PubMed ID: 15340092
[TBL] [Abstract][Full Text] [Related]
37. Biocompatibility of membranes used in the treatment of renal failure.
Hoenich NA; Woffindin C; Mathews JN; Vienken J
Biomaterials; 1995 May; 16(8):587-92. PubMed ID: 7548608
[TBL] [Abstract][Full Text] [Related]
38. Platelet-neutrophil interactions during hemodialysis: a proposed biocompatibility approach.
Stuard S; Bonomini M; Settefrati N; Albertazzi A
Int J Artif Organs; 1998 Feb; 21(2):75-82. PubMed ID: 9569128
[TBL] [Abstract][Full Text] [Related]
39. Influence of haemodialysis membranes on the release of granulocyte elastase.
Irvine L; Travers M; Simpson K; Lowe GD; Courtney JM
Int J Artif Organs; 1989 Aug; 12(8):502-4. PubMed ID: 2807595
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E
Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
